Tag: GCP compliance

Integrating QbD Into SOPs, Training and QMS Governance Integrating QbD Into SOPs, Training and QMS Governance Quality by Design (QbD) represents a paradigm shift in the approach to clinical trials, enhancing the efficiency, effectiveness, and regulatory compliance of clinical research. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs…

Read More “Integrating QbD Into SOPs, Training and QMS Governance” »

Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes The integration of Quality by Design (QbD) principles into clinical research has become a focal point for improving the efficiency and effectiveness of clinical trials. This step-by-step tutorial guide aims to equip clinical…

Read More “Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes” »

Identifying Critical-to-Quality Factors During Protocol Development Identifying Critical-to-Quality Factors During Protocol Development Introduction to Critical-to-Quality Factors in Clinical Trials The development of clinical trial protocols is a critical step in ensuring the success of pharmaceutical research and ultimately, the therapeutic benefits for patients. Within this framework, identifying Critical-to-Quality (CTQ) factors during protocol development has emerged…

Read More “Identifying Critical-to-Quality Factors During Protocol Development” »

Embedding QbD Principles Into Study Design, Feasibility and Vendor Set-Up Embedding QbD Principles Into Study Design, Feasibility and Vendor Set-Up Quality by Design (QbD) principles provide a systematic approach for pharmaceutical clinical trials, focusing on quality assurance throughout the study process. This article serves as a comprehensive tutorial aimed at clinical operations, regulatory affairs, and…

Read More “Embedding QbD Principles Into Study Design, Feasibility and Vendor Set-Up” »

Using QbD Workshops to Align Medical, Statistics, Operations and Quality Quality by Design (QbD) is a systematic approach to pharmaceutical development that emphasizes proactive quality assurance measures. In clinical trial settings, particularly during a phase 3b clinical trial, effective alignment across various departments—such as medical, statistics, operations, and quality—is crucial for success. This article presents…

Read More “Using QbD Workshops to Align Medical, Statistics, Operations and Quality” »

QbD Tools and Templates: CTQ Tables, Risk Registers and Control Plans QbD Tools and Templates: CTQ Tables, Risk Registers and Control Plans Introduction to Quality by Design in Clinical Trials Quality by Design (QbD) is a proactive approach that emphasizes the inclusion of quality into the design of pharmaceutical products and clinical trials. Its principles…

Read More “QbD Tools and Templates: CTQ Tables, Risk Registers and Control Plans” »

Linking QbD Activities to KRIs, QTLs and Monitoring Strategies Linking QbD Activities to KRIs, QTLs and Monitoring Strategies In the regulatory landscape of pharma clinical trials, the application of Quality by Design (QbD) has emerged as a pivotal regulatory strategy. This comprehensive guide focuses on linking QbD activities to Key Risk Indicators (KRIs), Quality Tolerance…

Read More “Linking QbD Activities to KRIs, QTLs and Monitoring Strategies” »